81 related articles for article (PubMed ID: 2399491)
21. Similar potencies of CCK-8 and its analogue BOC(Nle28;Nle31)CCK27-33 on the self-stimulation behaviour both are antagonized by a newly synthesized cyclic CCK analogue.
Heidbreder C; Roques BP; De Witte P
Neuropeptides; 1989; 13(2):89-94. PubMed ID: 2739884
[TBL] [Abstract][Full Text] [Related]
22. CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives.
Corringer PJ; Weng JH; Ducos B; Durieux C; Boudeau P; Bohme A; Roques BP
J Med Chem; 1993 Jan; 36(1):166-72. PubMed ID: 8421283
[TBL] [Abstract][Full Text] [Related]
23. SNF9007: a novel analgesic that acts simultaneously at delta 1, delta 2 and mu opioid receptors.
Williams CL; Rosenfeld GC; Dafny N; Fang SN; Hruby VJ; Bowden G; Cullinan CA; Burks TF
J Pharmacol Exp Ther; 1994 May; 269(2):750-5. PubMed ID: 8182541
[TBL] [Abstract][Full Text] [Related]
24. Binding sites and transduction process of the cholecystokininB receptor: involvement of highly conserved aromatic residues of the transmembrane domains evidenced by site-directed mutagenesis.
Jagerschmidt A; Guillaume N; Roques BP; Noble F
Mol Pharmacol; 1998 May; 53(5):878-85. PubMed ID: 9584214
[TBL] [Abstract][Full Text] [Related]
25. CCKA and CCKB receptors are expressed in small cell lung cancer lines and mediate Ca2+ mobilization and clonal growth.
Sethi T; Herget T; Wu SV; Walsh JH; Rozengurt E
Cancer Res; 1993 Nov; 53(21):5208-13. PubMed ID: 8221657
[TBL] [Abstract][Full Text] [Related]
26. Peptidomimetics as receptors agonists or peptidase inhibitors: a structural approach in the field of enkephalins, ANP and CCK.
Roques BP
Biopolymers; 1992 Apr; 32(4):407-10. PubMed ID: 1320419
[TBL] [Abstract][Full Text] [Related]
27. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors.
Boteju LW; Nikiforovich GV; Haskell-Luevano C; Fang SN; Zalewska T; Stropova D; Yamamura HI; Hruby VJ
J Med Chem; 1996 Sep; 39(20):4120-4. PubMed ID: 8831778
[TBL] [Abstract][Full Text] [Related]
28. Peripheral stimulation of CCK-B receptors by BC264 induces a hyperexploration, dependent on the delta opioid system in the nucleus accumbens of rat.
Daugé V; Samir A; Cupo A; Roques BP
Neuropharmacology; 1999 Jul; 38(7):999-1007. PubMed ID: 10428418
[TBL] [Abstract][Full Text] [Related]
29. CCKA, but not CCKB, agonists suppress the hyperlocomotion induced by endogenous enkephalins, protected from enzymatic degradation by systemic RB 101.
Dauge V; Corringer PJ; Roques BP
Pharmacol Biochem Behav; 1995 Feb; 50(2):133-9. PubMed ID: 7740050
[TBL] [Abstract][Full Text] [Related]
30. Neuromedin N mimics the actions of neurotensin in the ventral tegmental area but not in the nucleus accumbens.
Kalivas PW; Richardson-Carlson R; Duffy P
J Pharmacol Exp Ther; 1986 Sep; 238(3):1126-31. PubMed ID: 3755755
[TBL] [Abstract][Full Text] [Related]
31. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors.
Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH
Cancer Res; 1993 Sep; 53(17):3925-9. PubMed ID: 8358719
[TBL] [Abstract][Full Text] [Related]
32. Determination of RNA expression for cholecystokinin/gastrin receptors (CCKA, CCKB and CCKC) in human tumors of the central and peripheral nervous system.
Lefranc F; Chaboteaux C; Belot N; Brotchi J; Salmon I; Kiss R
Int J Oncol; 2003 Jan; 22(1):213-9. PubMed ID: 12469207
[TBL] [Abstract][Full Text] [Related]
33. Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations.
Kõks S; Männistö PT; Bourin M; Shlik J; Vasar V; Vasar E
J Psychiatry Neurosci; 2000 Jan; 25(1):33-42. PubMed ID: 10721682
[TBL] [Abstract][Full Text] [Related]
34. Effect of a highly selective central CCK-B receptor agonist: BC-264 on rat sleep.
de Saint Hilaire Z; Roques BP; Nicolaïdis S
Pharmacol Biochem Behav; 1991 Mar; 38(3):545-8. PubMed ID: 2068190
[TBL] [Abstract][Full Text] [Related]
35. Conformational behavior of cyclic CCK-related peptides determined by 400-MHz 1H-NMR: relationships with affinity and selectivity for brain receptors.
Roy P; Charpentier B; Durieux C; Dor A; Roques BP
Biopolymers; 1989 Jan; 28(1):69-79. PubMed ID: 2720122
[TBL] [Abstract][Full Text] [Related]
36. CR 2945: a novel CCKB receptor antagonist with anxiolytic-like activity.
Revel L; Mennuni L; Garofalo P; Makovec F
Behav Pharmacol; 1998 May; 9(3):183-94. PubMed ID: 9832933
[TBL] [Abstract][Full Text] [Related]
37. The CCK-B agonist, BC264, increases dopamine in the nucleus accumbens and facilitates motivation and attention after intraperitoneal injection in rats.
Ladurelle N; Keller G; Blommaert A; Roques BP; Daugé V
Eur J Neurosci; 1997 Sep; 9(9):1804-14. PubMed ID: 9383203
[TBL] [Abstract][Full Text] [Related]
38. Electrophysiological studies with new CCK analogs: correlation with binding affinity on B-type receptors.
Böhme GA; Durieux C; Stutzmann JM; Charpentier B; Roques BP; Blanchard JC
Peptides; 1989; 10(2):407-14. PubMed ID: 2755879
[TBL] [Abstract][Full Text] [Related]
39. CCK-8-related C-terminal tetrapeptides: affinities for central CCKB and peripheral CCKA receptors.
Harhammer R; Schäfer U; Henklein P; Ott T; Repke H
Eur J Pharmacol; 1991 Dec; 209(3):263-6. PubMed ID: 1797567
[TBL] [Abstract][Full Text] [Related]
40. Opposite role of CCKA and CCKB receptors in the modulation of endogenous enkephalin antidepressant-like effects.
Smadja C; Maldonado R; Turcaud S; Fournie-Zaluski MC; Roques BP
Psychopharmacology (Berl); 1995 Aug; 120(4):400-8. PubMed ID: 8539320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
